IQVIA Stock Pops After It Beats Q2 Earnings Estimates [Video]

IQVIA Holdings (IQV) beat second-quarter earnings expectations and raised its full-year outlook on Monday, sending shares higher.

The life sciences clinical research and analytics organization posted adjusted earnings per share (EPS) of $2.64, topping analysts’ expectations of $2.57, per Visible Alpha. Revenue was $3.81 billion, above projections of $3.79 billion. 

The results were driven by IQVIA’s Technology & Analytics Solutions (TAS) segment, which posted year-over-year sales growth of 2.7% to $1.5 billion. 

“IQVIA delivered second-quarter results at the high end of our guidance, driven mainly by better-than-expected TAS performance,” Chief Executive Officer (CEO) Ari Bousbib said.

Looking ahead, IQVIA narrowed its full-year revenue guidance to a range of $15.43 billion to $15.53 billion from its prior forecast of $15.33 billion to $15.58 billion. It also raised its adjusted EPS outlook to between $11.10 and $11.30 from $10.95 to $11.25.

Shares of IQVIA jumped 6.6% to $239.45 as of 1:41 p.m. ET Monday to move into positive …